344
Views
1
CrossRef citations to date
0
Altmetric
EDITORIAL

Could pharmacogenetics play a role as predictor in treatment of depressive disorders?

, PhD , MD
Pages 2-3 | Published online: 12 Jul 2009

References

  • Delgado PL, Miller HL, Salomon RM, Licinio J, Heninger GR, Gelenberg AJ, Charney DS. Monoamines and the mechanism of antidepressant action: effects of catecholamine depletion on mood of patients treated with antidepressants. Psychopharmacol Bull 1993; 29: 389–396
  • Lee MS. The pharmacogenetics of antidepressant treatments for depressive disorders. Drug Dev Res 2005; 65: 170–178
  • Mossner R, Daniel S, Albert D, Heils A, Okladnova O, Schmitt A, Lesch KP. Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF). Neurochem Int 2000; 36: 197–202
  • Wang JH, Liu ZQ, Wang W, Chen XP, Shu Y, He N, Zhou HH. Pharmacokinetics of sertraline in relation to genetic polymorphism of CYP2C19. Clin Pharmacol Ther 2001; 70: 42–47

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.